Similar articles

Abstract: Originating in China, tea and tea planting have spread throughout the world since the middle of the Tang dynasty. Now people from 160 countries in the world are accustomed to tea drinking. A brief history of tea’s medicinal role in China and its spread to the world are introduced. The effectiveness of tea active components and tea drinking on major human diseases, including cancer, metabolic syndrome, cardiovascular disease, and neurodegenerative diseases, is discussed. Also presented are some related issues, such as the bioavailability of tea active components, the new formulations of tea polyphenols, and the safety for consumers of dietary supplements containing tea polyphenols.

茶与人体健康:茶叶活性组分的生物医学效应和当前关注的若干问题

[1]Adhami, V.M., Siddiqui, J.A., Ahmad, N., et al., 2004. Oral consumption of 5 green tea polyphenols inhibits insulin-like growth factor-l-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res., 64(23):8715-8722.

[2]Arab, L., Biggs, M.L., O’Meara, E.S., et al., 2011. Gender differences in tea, coffee and cognitive decline in the elderly: the cardiovascular health study. J. Alzheimer’s Dis., 27(3):553-566.

[3]Arts, I.C., 2008. A review of the epidemiological evidence on tea, flavonoids, and lung cancer. J. Nutr., 138(8):1561S-1566S.

[4]Auvichayapat, P., Prapochanung, M., Tunkamnerdthai, O., et al., 2008. Effectiveness of green tea on weight reduction in obese Thais: a randomized controlled trial. Physiol. Behav., 93(3):486-491.

[5]Barranco, Q.J.L., Allam, M.F., del Castillo, A.S., et al., 2009. Parkinson’s disease and tea: a quantitative review. J. Am. Coll. Nutr., 28(1):1-6.

[6]Bastianetto, S., Han, Y.S., Rémi, Q., 2005. Green tea and resveratrol as protective agents against neurotoxins. In: Luo, Y., Packer, L. (Eds.), Oxidative Stress and Age-Related Neurodegeneration. CRC Press, Boca Raton, FL, USA, p.225-234.

[7]Basu, A., Sanchez, K., Leyva, N.M., et al., 2011. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition, 27(2):206-213.

[8]Bérubé-Parent, S., Pelletier, C., Doré, J., et al., 2005. Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men. Br. J. Nutr., 94(3):432-436.

[9]Bettuzzi, S., Brausi, M., Rizzi, F., et al., 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res., 66(2):1234-1240.

[10]Boehm, K., Borrelli, F., Ernst, E., et al., 2009. Green tea for the prevention of cancer. Cochrane Database Syst. Rev., CD005004.

[11]Bøhn, S.K., Ward, N.C., Hodgson, J.M., et al., 2012. Effects of tea and coffee on cardiovascular disease risk. Food Funct., 3(6):575-591.

[12]Bohn, T., 2014. Dietary factors affecting polyphenol bio-availability. Nutr. Rev., 72(7):429-452.

[13]Bonner, M.R., Rothman, N., Mumford, J.L., et al., 2005. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer. Mutat. Res. Gen. Toxicol. Envir. Mutag., 582(1-2):53-60.

[14]Chan, C.C., Kao, M.W., Ng, E.H., et al., 2006. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—a randomized placebo-controlled trial. J. Soc. Gynecol. Investig., 13(1):63-68.

[15]Chang, C.S., Chang, Y.F., Liu, P.Y., et al., 2012. Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao old people (TOP) study 02. PLoS ONE, 7(6):e38874.

[16]Chantre, P., Lairon, D., 2002. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine, 9(1):3-8.

[17]Checkoway, H., Powers, K., Smith-Weller, T., et al., 2002. Parkinson’s disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol., 155(8):732-738.

[18]Chen, L., Lee, M.J., Li, H., et al., 1997. Absorption, distribution, elimination of tea polyphenols in rats. Drug Metab. Dispos., 25(9):1045-1050.

[19]Clement, Y., 2009. Can green tea do that? A literature review of the clinical evidence. Prev. Med., 49(2-3):83-87.

[20]Dai, Q., Shu, X.O., Li, H., et al., 2010. Is green tea drinking associated with a later onset of breast cancer? Ann. Epidemiol., 20(1):74-81.

[21]da Silva Pinto, M., 2013. Tea: a new perspective on health benefits. Food Res. Int., 53(2):558.

[22]Deka, A., Vita, J.A., 2011. Tea and cardiovascular disease. Pharmacol. Res., 64(2):136-145.

[23]de Koning Gans, J.M., Uiterwaal, C.S., van der Schouw, Y.T., et al., 2010. Tea and coffee consumption and cardiovascular morbidity and mortality. Aterioscler. Thromb. Vasc. Biol., 30(8):1665-1671.

[24]Dufresne, C.J., Farnworth, E.R., 2001. A review of latest research findings on the health promotion properties of tea. J. Nutr. Biochem., 12(7):404-421.

[25]Fassina, G., Venè, R., Morini, M., et al., 2004. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate. Clin. Cancer Res., 10(14):4865-4873.

[26]Feng, L., Ng, T.P., Kua, E.H., et al., 2013. Tea and the cognitive function of elderly people: evidence from neurobiology and epidemiology. In: Preedy, V.R. (Ed.), Tea in Health and Disease Prevention. AP Press, London, p.1325-1336.

[27]Fujiki, H., Imai, K., Nakachi, K., et al., 2012. Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol., 138(8):1259-1270.

[28]Galanis, D.J., Kolonel, L.N., Lee, J., et al., 1998. Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: a prospective study. Int. J. Epidemiol., 27(2):173-180.

[29]Gao, Y.T., McLaughlin, J.K., Blot, W.J., 1994. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst., 86(11):855-858.

[30]Grundy, S.M., Cleeman, J.I., Daniels, S.R., et al., 2005. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112(17):2735-2752.

[31]Gupta, S., Hastak, K., Ahmad, N., et al., 2001. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. PNAS, 98(18):10350-10355.

[32]Henning, S.M., Wang, P.W., Heber, D., 2011. Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol. Nutr. Food Res., 55(6):905-920.

[33]Hosoda, K., Wang, M.F., Liao, M.L., et al., 2003. Antihypeglyceic effect of Oolong tea in type-2 diabetes. Diab. Care, 26(6):1714-1718.

[34]Hsu, Y.W., Tsai, C.F., Chen, W.K., et al., 2011. A subacute toxicity evaluation of green tea (Camellia sinensis) extract in mice. Food Chem. Toxicol., 49(10):2624-2631.

[35]Hu, G., Bidel, S., Jousilshti, P., et al., 2007. Coffee and tea consumption and the risk of Parkinson’s disease. Mov. Disord., 22(15):2242-2248.

[36]Huang, X., Tajima, K., Hamajima, N., et al., 1999. Effect of life styles on the risk of subsite-specific gastric cancer in those with and without family history. J. Epidemiol., 9(1):40-45.

[37]Hursel, R., Viechtbauer, W., Dulloo, A.G., et al., 2011. The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis. Obes. Rev., 12(7):573-581.

[38]Huxley, R., Lee, C.M., Barzi, F., et al., 2009. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch. Intern. Med., 169(22):2053-2063.

[39]Inoue, M., Tajima, K., Hirose, K., et al., 1998. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control, 9(2):209-216.

[40]Inoue, M., Robien, K., Wang, R., et al., 2008. Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenensis, 29(10):1967-1972.

[41]Isbrucker, R.A., Bausch, J., Edwards, J.A., et al., 2006a. Safety studies on epigallocatechin-3-gallate (EGCG) preparations. Part 1: genotoxicity. Food Chem. Toxicol., 44(5):626-635.

[42]Isbrucker, R.A., Edwards, J.A., Wolz, E., et al., 2006b. Safety studies on epigallocatechin-3-gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem. Toxicol., 44(5):636-650.

[43]Isbrucker, R.A., Bausch, J., Edwards, J.A., et al., 2006c. Safety studies on epigallocatechin-3-gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats. Food Chem. Toxicol., 44(5):651-661.

[44]Iso, H., Date, C., Wakai, K., et al., 2006. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann. Int. Med., 144(8):554-562.

[45]Iwasaki, M., Inoue, M., Sasazuki, S., et al., 2010. Green tea drinking and subsequent risk of breast cancer in a population to based cohort of Japanese women. Breast Cancer Res., 12(5):R88.

[46]Jäger, A.K., Saaby, L., 2011. Flavonoids and the CNS. Molecules, 16(2):1471-1485.

[47]Ju, J., Hong, J., Zhou, J.N., et al., 2005. Inhibition of intestinal tumorigenesis in Apc^min/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res., 65(22):10623-10631.

[48]Kakuda, T., 2011. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol. Res., 64(2):162-168.

[49]Kanwar, J., Taskeen, M., Mohammad, I., et al., 2012. Recent advances on tea polyphenols. Front. Biosci., 4(1):111-131.

[50]Kim, S., Lee, M.J., Hong, J., et al., 2000. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer, 37(1):41-48.

[51]Komatsu, T., 2003. Oolong tea increases energy metabolism in Japanese females. J. Med. Invest., 50(3-4):170-175.

[52]Kovacs, E.M., Lejeune, M.P., Nijs, I., et al., 2004. Effects of green tea on weight maintenance after body-weight loss. Br. J. Nutr., 91(3):431-437.

[53]Krishna, Y.R., Mittal, V., Grewal, P., et al., 2011. Acute liver failure caused by ‘fat burners’ and dietary supplements: a case report and literature review. Can. J. Gastroenterol., 25(3):157-160.

[54]Kumazoe, M., Sugihara, K., Tsukamoto, S., et al., 2013. 67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis. J. Clin. Invest., 123(2):787-799.

[55]Kurahashi, N., Sasazuki, S., Iwasaki, M., et al., 2008. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Am. J. Epidemiol., 167(1):71-77.

[56]Kuriyama, S., Shimazu, T., Ohmori, K., et al., 2006. Green tea consumption and mortality due to cardiovascular disease, cancer and all causes in Japan: the Ohsaki study. JAMA, 296(10):1255-1265.

[57]Lambert, J.D., Lee, M.J., Lu, H., et al., 2003. Epigallocatechin-3-gallate is absorbed but extensively gucuronidated following oral administration to mice. J. Nutr., 133(12):4172-4177.

[58]Lambert, J.D., Sang, S., Hong, J., et al., 2006. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos., 34(12):2111-2116.

[59]Lambert, J.D., Sang, S., Lu, A.Y., et al., 2007. Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab., 8(5):499-507.

[60]Lambert, J.D., Kennett, M.J., Sang, S., et al., 2010. Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice. Food Chem. Toxicol., 48(1):409-416.

[61]Landis-Piwowar, K.R., Huo, C.D., Chen, D., et al., 2007. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J. Cell. Physiol., 213(1):252-260.

[62]Lee, M.J., Maliakal, P., Chen, L., et al., 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (−)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev., 11(10 Pt 1):1025-1032.

[63]Lee, S.R., Im, K.J., Suh, S.I., et al., 2003. Protective effect of green tea polyphenol (−)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Phytother. Res., 17(3):206-209.

[64]Lee, W.J., Shim, J.Y., Zhu, B.T., 2005. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol., 68(4):1018-1030.

[65]Leong, H., Mathur, P.S., Geene, G.L., 2008. Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green tea. Breast Cancer Res. Treat., 107(3):359-369.

[66]Li, F.J., Ji, H.F., Shen, L., 2012. A meta-analysis of tea drinking and risk of Parkinson’s disease. Sci. World J., 923464.

[67]Li, Q., Kakizuki, M., Kuriyama, S., et al., 2008. Green tea consumption and lung cancer risk: the Ohsaki study. Br. J. Cancer, 99(7):1179-1184.

[68]Lipinski, C.A., Lombardo, F., Dominy, B.W., et al., 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and developmental settings. Adv. Drug Deliv. Rev., 46(1-3):3-25.

[69]Lu, G., Xiao, H., You, H., et al., 2008. Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atrovastatin. Clin. Cancer Res., 14(15):4981-4988.

[70]Mair, V.H., Hoh, E., 2009. The True History of Tea. Thames Hudson, London.

[71]Maki, K.C., Reeves, M.S., Farmer, M., et al., 2009. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J. Nutr., 139(2):264-270.

[72]Mazzanti, G., Menniti-Ippolito, F., Moro, P.A., et al., 2009. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol., 65(4):331-341.

[73]Mineharu, Y., Koizumi, A., Wada, Y., et al., 2011. Coffee, green tea, black tea and Oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J. Epidemiol. Community Health, 65(3):230-240.

[74]Myung, S.K., Bae, W.K., Oh, S.M., et al., 2009. Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int. J. Cancer, 124(3):670-677.

[75]Nagano, J., Kono, S., Preston, D.L., et al., 2001. A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control, 12(6):501-508.

[76]Nagao, T., Komine, Y., Soga, S., et al., 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am. J. Clin. Nutr., 81(1):122-129.

[77]Nagao, T., Hase, T., Tokimitsu, I., 2007. A green tea extract high in catechins reduces body fat and cardiovascular risk in humans. Obesity, 15(6):1473-1483.

[78]Nakachi, K., Matsuyama, S., Miyake, S., et al., 2000. Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors, 13(1-4):49-54.

[79]Nakagawa, K., Miyazawa, T., 1997. Absorption and distribution of tea catechin, (‒)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol., 43(6):679-684.

[80]Nurk, E., Refsum, H., Drevon, C.A., et al., 2009. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J. Nutr., 139(1):120-127.

[81]Oak, M.H., Bedoui, J.E., Schini-Kerth, V.B., 2005. Antiagiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem., 16(1):1-8.

[82]Ogunleye, A.A., Xue, F., Michels, K.B., 2010. Green tea consumption and breast cancer risk of recurrence: a meta-analysis. Breast Cancer Res. Treat., 119(2):477-484.

[83]Ogura, R., Ikeda, N., Yuki, K., et al., 2008. Genotoxicity studies on green tea catechin. Food Chem. Toxicol., 46(6):2190-2200.

[84]Ohno, Y., Wakai, K., Genka, K., 1995. Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn. J. Cancer Res., 86(11):1027-1034.

[85]Oi, Y., Hou, I.C., Fujita, H., et al., 2012. Antiobesity effects of Chinese black tea (Pu-erh tea) extract and gallic acid. Phytother. Res., 26(4):475-481.

[86]Osanai, K., Landis-Piwowar, K.R., Dou, Q.P., et al., 2007. A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer celosis inducer. Bioorg. Med. Chem., 15:492-496.

[87]Pearson, D.A., Frakel, E.N., Aeschbach, R., et al., 1998. Inhibition of endothelial cell mediated low-density lipoprotein oxidation by green tea extracts. J. Agric. Food Chem., 46(4):1445-1449.

[88]Pham-Huy, L.A.N., He, H., Pham-Huy, C., 2008. Green tea and health: an overview. J. Food Agric. Environ., 6(1):6-13.

[89]Phung, O.J., Baker, W.L., Matthews, L.J., et al., 2010. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am. J. Clin. Nutr., 91(1):73-81.

[90]Potenza, M.A., Marasciulo, F.L., Tarquinio, M., et al., 2007. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab., 292(5):E1378-E1387.

[91]Rodriguez, S.K., Guo, W., Liu, L., et al., 2006. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int. J. Cancer, 118(7):1635-1644.

[92]Sae-tan, S., Grove, K.A., Lambert, J.D., 2011. Weight control and prevention of metabolic syndrome by green tea. Phamacol. Res., 64(2):146-154.

[93]Saleh, I.G., Ali, Z., Abe, N., et al., 2013. Effect of green tea and its polyphenols on mouse liver. Fitoterapia, 90: 151-159.

[94]Sano, J., Inami, S., Seimiya, K., et al., 2004. Effects of green tea intake on the development of coronary artery disease. Circul. J., 68(7):665-670.

[95]Sarma, D.N., Barrett, M.L., Chavez, M.L., et al., 2008. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Safety, 31(6):469-484.

[96]Schönthal, A.H., 2011. Adverse effects of concentrated green tea extracts. Mol. Nutr. Food Res., 55(6):874-885.

[97]Seely, D., Mills, E.J., Wu, P., et al., 2005. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systemic review and meta-analysis. Integr. Cancer Ther., 4(2):144-155.

[98]Shimizu, M., Deguchi, A., Hara, Y., et al., 2005. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun., 334(3):947-953.

[99]Shrubsole, M.J., Lu, W., Chen, Z., et al., 2009. Drinking green tea modestly reduces breast cancer risk. J. Nutr., 139(2):310-316.

[100]Shutava, T.G., Balkundi, S.S., Vangala, P., et al., 2009. Layer-by-layer-coated gelatin nanoparticles as a vehicle for delivery of natural polyphenols. ACS Nano, 3(7):1877-1885.

[101]Siddiqui, I.A., Adhami, V.M., Bharali, D.J., et al., 2009. Introducing nanochemoprervention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res., 69(5):1712-1716.

[102]Siddiqui, I.A., Adhami, V.M., Ahmad, N., et al., 2010. Nanochemoprervention: sustained release of bioactive food components for cancer prevention. Nutr. Cancer, 62(7):883-890.

[103]Song, Y., Manson, J.E., Buring, J.E., et al., 2005. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J. Am. Coll. Nutr., 24(5):376-384.

[104]Suganuma, M., Okabe, S., Marino, M.W., et al., 1999. Essential role of tumor necrosis factor-α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice. Cancer Res., 59(18):4516-4518.

[105]Suganuma, M., Okabe, S., Kai, Y., et al., 2010. Synergistic effects of (−)-epigallocatechin-3-gallate with (−)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res., 59(1):44-47.

[106]Suganuma, M., Saha, A., Fujiki, H., 2011. New cancer treatment stratedy using combination of green tea catechins and anticancer drugs. Cancer Sci., 102(2):317-323

[107]Sun, C.L., Yuan, J.M., Lee, M.J., et al., 2002. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenensis, 23(9):1497-1503.

[108]Sun, C.L., Yuan, J.M., Koh, W.P., et al., 2006. Green tea and black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis, 27(7):1301-1309.

[109]Sun, C.L., Yuan, J.M., Koh, W.P., et al., 2007. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis, 28(10):2143-2148.

[110]Suzuki, Y., Tsubono, Y., Nakaya, N., et al., 2004. Green tea and the risk of breast cancer: pooled analysis of two prospective studies in Japan. Br. J. Cancer, 90(7):1361-1363.

[111]Tan, E.K., Tan, C., Fook-Chong, S.M., et al., 2003. Dose-dependent protective effect of coffee, tea, and smoking in Parkinson’s disease: a study in ethnic Chinese. J. Neurol. Sci., 216(1):163-167.

[112]Tang, N., Wu, Y., Zhou, B., et al., 2009. Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer, 65(3):274-283.

[113]Thielecke, F., Boschmann, M., 2009. The potential role of green tea catechins in the prevention of the metabolic syndrome—a review. Phytochemistry, 70(1):11-24.

[114]Tsuneki, H., Ishizuka, M., Terasawa, M., et al., 2004. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC pharmacol., 4(1):18.

[115]Ullmann, U., Haller, J., Decourt, J.P., et al., 2003. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res., 31(2):88-101.

[116]Unno, T., Suzuki, Y., Kakuda, T., et al., 1999. Metabolism of theanine, γ-glutamylethylamide, in rats. J. Agric. Food Chem., 47(4):1593-1596.

[117]Venables, M.C., Hulstron, C.J., Cox, H.R., et al., 2008. Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am. J. Clin. Nutr., 87(3):778-784.

[118]Vernarelli, J.A., Lambert, J.D., 2013. Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults. Eur. J. Nutr., 52(3):1039-1048.

[119]Vita, J.A., 2003. Tea consumption and cardiovascular disease: effects on endothelial function. J. Nutr., 133(10):3293S-3297S.

[120]Wang, H., Wen, Y., Du, Y., et al., 2010. Effect of catechin enriched green tea on body composition. Obesity, 18(4):773-779.

[121]Wu, A.H., Yu, M.C., 2006. Tea, hormone-related cancers and endogenous hormone levels. Mol. Nutr. Food Res., 50(2):160-169.

[122]Wu, A.H., Butler, L.M., 2011. Green tea and breast cancer. Mol. Nutr. Food Res., 55(6):921-930.

[123]Wu, A.H., Yu, M.C., Tseng, C.C., et al., 2003. Green tea and risk of breast cancer in Asian Americans. Int. J. Cancer, 106(4):574-579.

[124]Wu, A.H., Yu, M.C., Tseng, C.C., et al., 2007. Body size, hormone therapy and risk of breast cancer in Asian American women. Int. J. Cancer, 120(4):844-852.

[125]Wu, C.H., Lu, F.H., Chang, T.C., et al., 2003. Relationship among habitual tea consumption, percent body fat, and body fat distribution. Obesity, 11(9):1088-1095.

[126]Xu, R., Ye, H., Sun, Y., et al., 2012. Preparation, preliminary characterization, antioxidant, hepatoprotective and antitumor activities of polysaccharides from the flower of tea plant (Camellia sinensis). Food Chem. Toxicol., 50(7):2473-2480.

[127]Yang, C.S., Hong, J., 2013. Prevention of chronic diseases by tea: possible mechanisms and human relevance. Ann. Rev. Nutr., 33(1):161-181.

[128]Yang, C.S., Lee, M.J., Chen, L., et al., 1999. Human salivary tea catechin levels and catechin esterase activities implication in human cancer prevention studies. Cancer Epidemiol. Biomarkers Prev., 8(1):83-89.

[129]Yang, C.S., Lu, F.H., Wu, J.S., et al., 2004. The protective effect of habitual tea consumption on hypertension. Arch. Intern. Med., 164(14):1534-1540.

[130]Yang, C.S., Lambert, J.D., Hou, Z., et al., 2006. Molecular targets for the cancer preventive activity of tea polyphenols. Mol. Carcinog., 45(6):431-435.

[131]Yang, C.S., Wang, X., Lu, G., et al., 2009. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer, 9(6):429-439.

[132]Yang, C.S., Wang, H., Li, G.X., et al., 2011. Cancer prevention by tea: evidence from laboratory studies. Pharmacol. Res., 64(2):113-122.

[133]Yang, G., Shu, X.O., Li, H., et al., 2007. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev., 16(6):1219-1223.

[134]Yuan, J.M., Koh, W.P., Sun, C.L., et al., 2005. Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore. Carcinogenesis, 26(8):1389-1394.

[135]Yuan, J.M., Sun, C., Butler, L.M., 2011. Tea and cancer prevention: epidemiological studies. Pharmacol. Res., 64(2):123-135.

[136]Yusuf, S., Hawken, S., Ôunpuu, S., et al., 2005. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet, 366(9497):1640-1649.

[137]Zhang, M., Holman, C.D., Huang, J.P., et al., 2007. Green tea and the prevention of breast cancer: a case-control study in Southeast China. Carcinogenesis, 28(5):1074-1078.

[138]Zhou, Y., Li, N., Zhuang, W., et al., 2008. Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac. J. Clin. Nutr., 17(1):159-165.